Peter H. Schur

Q: What Schools Are Affiliated With Peter H. Schur

Peter H. Schur is affiliated with the following schools: Montana State University, Icahn School of Medicine at Mount Sinai

Peter H. Schur's AcademicInfluence.com Rankings

Peter H. Schur

Philosophy

#4669

World Rank

#7275

Historical Rank

Logic

#2079

World Rank

#2986

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Peter H. Schur's Degrees

Doctorate Medicine Harvard University

Why Is Peter H. Schur Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Peter H. Schur's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. (1999) (1841)
IMMUNOLOGICAL STUDIES CONCERNING THE NEPHRITIS OF SYSTEMIC LUPUS ERYTHEMATOSUS (1967) (800)
Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. (1989) (794)
Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. (1966) (737)
Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. (1992) (551)
Immunologic factors and clinical activity in systemic lupus erythematosus. (1968) (537)
Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. (1996) (482)
Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. (2002) (472)
Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens. (1980) (462)
ANA screening: an old test with new recommendations (2010) (457)
Measurement of serum DNA-binding activity in systemic lupus erythematosus. (1969) (409)
Clinical utility of the anti-CCP assay in patients with rheumatic diseases (2003) (311)
Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus. (1982) (306)
Guidelines for referral and management of systemic lupus erythematosus in adults. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines. (1999) (279)
The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials. (2006) (242)
Proteins Phosphorylated during Stress-induced Apoptosis Are Common Targets for Autoantibody Production in Patients with Systemic Lupus Erythematosus (1997) (233)
Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE). (1981) (229)
IgG subclasses--a review. (1987) (227)
Selective gamma-g globulin deficiencies in patients with recurrent pyogenic infections. (1970) (224)
Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus. (1980) (221)
Inherited deficiency of the second component of complement. Rheumatic disease associations. (1976) (212)
Acquired C1 inhibitor deficiency in lymphosarcoma (1972) (206)
Activation of the properdin pathway of complement in patients with gram-negative of bacteremia. (1975) (187)
Psoriatic arthritis: a clinical, immunologic and HLA study of 100 patients. (1979) (183)
Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus. (1986) (183)
Deoxyribonucleic Acid ( DNA ) and Antibodies to DNA in the Serum of Patients with Systemic Lupus Erythematosus * (176)
The psychosocial impact of systemic lupus erythematosus and rheumatoid arthritis. (1984) (173)
A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythematosus. (1990) (166)
Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria. (1985) (158)
Renal tubular acidosis, glomerulonephritis and immunologic factors in Sjögren's syndrome. (1968) (154)
Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders. (2003) (145)
Measurement of fatigue in systemic lupus erythematosus: a systematic review. (2007) (138)
Immunoglobulin Subclasses in Normal Children (1979) (138)
Lymphocyte surface immunoglobulins. Distribution and frequency in lymphoproliferative diseases. (1973) (137)
The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity. (2004) (135)
pH gradient elution of human IgG1, IgG2 and IgG4 from protein A-sepharose. (1979) (135)
A controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus. (1992) (128)
Effects of aerobic conditioning in lupus fatigue: a pilot study. (1989) (124)
Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants. (2014) (122)
Circulating anticoagulants to factor VIII. Immunochemical studies and clinical response to factor VIII concentrates. (1970) (120)
Serum complement component levels in human glomerulonephritis. (1971) (117)
Metabolism of third complement component (C3) in nephritis. Involvement of the classic and alternate (properdin) pathways for complement activation. (1972) (116)
Autoantibodies frequently detected in patients with aplastic anemia. (2003) (109)
Silicone breast implants and rheumatic disease. Clinical, immunologic, and epidemiologic studies. (1994) (108)
Complement in human disease. (1968) (105)
Comparison of Threshold Cutpoints and Continuous Measures of Anti-Cyclic Citrullinated Peptide Antibodies in Predicting Future Rheumatoid Arthritis (2009) (104)
Early-onset pauciarticular juvenile rheumatoid arthritis associated with human leukocyte antigen-DRw5, iritis, and antinuclear antibody. (1980) (103)
Enzyme immunoassay for antibodies to native DNA (1983) (102)
Z-DNA-specific antibodies in human systemic lupus erythematosus. (1983) (99)
IgG subclasses in human periodontal disease. I. Distribution and incidence of IgG subclass bearing lymphocytes and plasma cells. (1978) (95)
Influenzal vaccine response in systemic lupus erythematosus. (1978) (92)
Associations between systemic lupus erythematosus and the major histocompatibility complex: clinical and immunological considerations. (1982) (92)
Associations of autoantibodies, autoimmune risk alleles, and clinical diagnoses from the electronic medical records in rheumatoid arthritis cases and non-rheumatoid arthritis controls. (2013) (91)
Hypocomplementemia in rheumatoid arthritis. (1971) (91)
Selective defect in the antibody response to Haemophilus influenzae type b in children with recurrent infections and normal serum IgG subclass levels. (1988) (84)
Precipitating antibodies to ribosomes in the serum of patients with systemic lupus erythematosus (1967) (84)
Studies of the antibodies in pemphigoid and pemphigus. (1973) (84)
Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-Sm and anti-RNP antibody tests. (2004) (84)
Antibodies to ribonucleic acid in systemic lupus erythematosus. (1969) (83)
Review: Genetics of systemic lupus erythematosus (1995) (82)
Abdominal thrombotic and ischemic manifestations of the antiphospholipid antibody syndrome: CT findings in 42 patients. (2001) (82)
Anti-cyclic citrullinated peptide revised criteria for the classification of rheumatoid arthritis (2008) (82)
Clinical laboratory test findings in patients with chronic fatigue syndrome. (1995) (81)
Erroneous augmentation of multiplex assay measurements in patients with rheumatoid arthritis due to heterophilic binding by serum rheumatoid factor. (2011) (80)
THE ROLE OF DISULFIDE BONDS IN THE COMPLEMENT-FIXING AND PRECIPITATING PROPERTIES OF 7S RABBIT AND SHEEP ANTIBODIES (1964) (79)
Rheumatoid arthritis associated with eosinophilia. (1971) (77)
Gamma G globulin subgroup composition of the glomerular deposits in human renal diseases. (1970) (76)
Deficiency of the C3b/C4b receptor (CR1) of erythrocytes in systemic lupus erythematosus: analysis of the stability of the defect and of a restriction fragment length polymorphism of the CR1 gene. (1987) (76)
Quantifying anti-cyclic citrullinated peptide titres: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis (2008) (74)
The effect of ethnicity on major histocompatibility complex complement allotypes and extended haplotypes in patients with systemic lupus erythematosus. (1990) (74)
Reference sera for antinuclear antibodies. I. Antibodies to native DNA, Sm, nuclear RNP, and SS-B/La. (1982) (73)
A screening strategy for population studies in systemic lupus erythematosus. Series design. (1980) (72)
The effect of antirheumatic drugs on interleukin 1 (IL-1) activity and IL-1 and IL-1 inhibitor production by human monocytes. (1990) (72)
Serum and synovial fluid IgG, IgA and IgM antigammaglobulins in rheumatoid arthritis. (1971) (72)
Radiographic findings in the hands in patients with systemic lupus erythematosus. (1978) (71)
The complement system in rheumatoid synovitis. II. Intracytoplasmic inclusions of immunoglobulins and complement. (1971) (70)
Antibodies to SM and RNP (1983) (70)
Expression of CD44 variant isoforms CD44v3 and CD44v6 is increased on T cells from patients with systemic lupus erythematosus and is correlated with disease activity. (2010) (69)
Reactions of aggregated mercaptoethanol treated gamma globulin with rheumatoid factor--precipitin and complement fixation studies. (1968) (64)
Utility of anti-Sm, anti-RNP, anti-Ro/SS-A, and anti-La/SS-B (extractable nuclear antigens) detected by enzyme-linked immunosorbent assay for the diagnosis of systemic lupus erythematosus. (1996) (64)
Elevation of Bioactive Transforming Growth Factor-β in Serum from Patients with Chronic Fatigue Syndrome (1997) (62)
Association of silicone breast implants with immunologic abnormalities: a prospective study. (1999) (62)
The γG subclass of antinuclear and antinucleic acid antibodies (1972) (61)
Molecular analysis of major histocompatibility complex allelic associations with systemic lupus erythematosus in Taiwan. (1997) (61)
Complement and lupus erythematosus. (1982) (59)
The chromosomal order of genes controlling the major histocompatibility complex, properdin factor B, and deficiency of the second component of complement. (1976) (58)
Inherited C2 deficiency and systemic lupus erythematosus: studies on a family. (1975) (57)
The effects of methotrexate on interleukin 1 in patients with rheumatoid arthritis. (1992) (57)
Barriers to a trial of atherosclerosis prevention in systemic lupus erythematosus. (2005) (55)
Immunologic studies of the proteins of human synovial fluid. (1963) (54)
Guidelines for immunologic laboratory testing in the rheumatic diseases: an introduction. (2002) (53)
Immunofluorescent localization of double-stranded RNA in reovirus-infected cells. (1970) (53)
Prospective analysis suggests susceptibility genes for deficiencies of IgA and several other immunoglobulins on the [HLA-B8, SC01, DR3] conserved extended haplotype. (2000) (53)
HEMOLYTIC ASSAY OF THE NINTH COMPLEMENT COMPONENT: ELEVATION AND DEPLETION IN RHEUMATIC DISEASES (1971) (53)
Association between a T cell receptor restriction fragment length polymorphism and systemic lupus erythematosus. (1990) (52)
The pathogenesis of autoimmunity in New Zealand mice. II. Acceleration of glomerulonephritis by polyinosinic-polycytidylic acid. (1970) (51)
Prevalence of Migraine in Patients With Systemic Lupus Erythematosus (2001) (51)
PEPSIN DIGESTION OF RABBIT AND SHEEP ANTIBODIES. THE EFFECT ON COMPLEMENT FIXATION. (1963) (51)
The IgG subclasses of red cell antibodies and relationship to monocyte binding. (1972) (51)
Frequency of anti-DNA antibody producing cells from normals and patients with systemic lupus erythematosus. (1983) (50)
Complement-human histocompatibility antigen haplotypes in C2 deficiency. (1981) (50)
Immunologic studies of juvenile rheumatoid arthritis. (1971) (49)
Association of polyarthritis, subcutaneous nodules, and pancreatic disease. (1975) (48)
Immunopathologic features of a patient with glomerulonephritis and pulmonary hemorrhage. (1973) (48)
Heavy chain subclass of human anti-platelet antibodies. (1973) (47)
Development and initial validation of a self‐assessed lupus organ damage instrument (2010) (47)
Incidence of antibodies to double-stranded RNA in systemic lupus erythematosus and related diseases. (1971) (47)
IgG subclasses. A historical perspective. (1988) (47)
Discordance between erythrocyte sedimentation rate and C-reactive protein measurements: clinical significance. (2007) (47)
Autoantibody to the C3b/C4b receptor and absence of this receptor from erythrocytes of a patient with systemic lupus erythematosus. (1985) (46)
Immunological detection of nucleic acids and antibodies to nucleic acids and nuclear antigens by counterimmunoelectrophoresis. (1974) (45)
Human gamma-g subclasses. (1972) (44)
Hereditary C2 deficiency: diagnosis and HLA gene complex associations. (1976) (42)
Lateralized cognitive dysfunction in patients with systemic lupus erythematosus (2005) (41)
COMPLEMENT COMPONENTS IN SYNOVIAL FLUID: ACTIVATION AND FIXATION IN SEROPOSITIVE RHEUMATOID ARTHRITIS * (1969) (41)
Circulating immune complexes in patients with necrotizing vasculitis. (1980) (40)
A computer based intervention to reduce unnecessary serologic testing. (1999) (39)
Antibodies to C reactive protein (2005) (39)
Antibodies to DNA in patients with rheumatoid arthritis and juvenile rheumatoid arthritis. (1975) (38)
Mapping of the structural gene for the second component of complement with respect to the human major histocompatibility complex. (1979) (38)
Immunologic characterization of the mononuclear cell infiltrates in rheumatoid synovia, in rheumatoid nodules, and in lip biopsies from patients with Sjögren's syndrome. (1975) (38)
Development of SLE among “potential SLE” patients seen in consultation: long‐term follow‐up (2014) (38)
The clinical management of systemic lupus erythematosus (1996) (37)
Heavy-chain subclass of round antiplatelet IgG in autoimmune thrombocytopenic purpura. (1980) (36)
Gm allotypes in white patients with systemic lupus erythematosus. (1985) (36)
Complement testing in the diagnosis of immune and autoimmune diseases. (1977) (34)
Juvenile rheumatoid arthritis. Cellular hypersensitivity and selective IgA deficiency. (1972) (34)
Immunological properties of isolated IgG and IgM anti-gamma-globulins (rheumatoid factors). (1974) (33)
Acute anaphylaxis associated with serum complement depletion. (1975) (33)
Development of reticulum cell sarcoma during cyclophosphamide therapy. (1974) (33)
Spontaneous "autoimmune disease" in nude mice. (1974) (32)
We Need Better Classification and Terminology for “People at High Risk of or in the Process of Developing Lupus” (2015) (31)
Complement studies of sera and other biologic fluids. (1983) (30)
Genetics of complement deficiencies associated with lupus-like syndromes. (1978) (30)
IgG subclasses in human periodontal disease. II. Cytophilic and membrane IgG subclass immunoglobulins. (1978) (30)
Human monocytes produce IL-1 and an inhibitor of IL-1 in response to two different signals. (1990) (29)
Rheumatoid factor detection by nephelometry. (1980) (28)
I-123 Iofetamine SPECT Scan in Systemic Lupus Erythematosus Patients with Cognitive and Other Minor Neuropsychiatric Symptoms: A Pilot Study (1992) (28)
Immunologic study of human periodontosis (juvenile periodontitis). (1981) (27)
DR3 and nonDR3 associated complement component C4A deficiency in systemic lupus erythematosus. (1991) (27)
Immune-complex assays: the state of the art. (1978) (27)
Disease associations with isolated elevations of each of the four IgG subclasses. (2017) (27)
Inherited deficiency of the sixth component of complement: a silent or null gene. (1978) (27)
Re-examination of histocompatibility antigens found in patients with juvenile rheumatoid arthritis. (1975) (27)
C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase. (1976) (26)
Association between HLA and cutaneous necrotizing venulitis. (1976) (25)
EEG Abnormalities in Systemic Lupus Erythematosus (1998) (25)
Genetics of systemic lupus erythematosus. (1995) (25)
Enzyme immunoassay for antibodies to native DNA. Specificity and quality of antibodies. (1983) (25)
Serological and clinical remission in systemic lupus erythematosus. (1985) (25)
The effect of interleukin 1 on IgG synthesis in systemic lupus erythematosus. (1987) (24)
Handedness in systemic lupus erythematosus. (1986) (23)
Impact of Cyclic Citrullinated Peptide Antibody Level on Progression to Rheumatoid Arthritis in Clinically Tested Cyclic Citrullinated Peptide Antibody–Positive Patients Without Rheumatoid Arthritis (2019) (23)
Humoral studies of periodontal disease. I. Characterization of immunoglobulins quantitated from cultures of gingival tissue. (1982) (23)
Lectin-dependent neutrophil-mediated cytotoxicity. I. Characteristics. (1976) (23)
Antibodies to Sm and RNP. Prognosticators of disease involvement. (1983) (23)
Inherited complement component abnormalities. (1986) (23)
IgG and IgG subclasses in human periodontosis (juvenile periodontitis). Serum concentrations. (1981) (22)
IgG subclasses: relationship to clinical aspects of multiple myeloma and frequency distribution among M-components. (2009) (22)
Asthma and elevation of anti-citrullinated protein antibodies prior to the onset of rheumatoid arthritis (2019) (22)
Ureaplasma urealyticum and Mycoplasma hominis in women with systemic lupus erythematosus. (1992) (22)
Binding of circulating immune complexes to human peripheral blood lymphocytes: effect of complement. (1978) (21)
Hypoimmunoglobulinemia D: frequency, family studies, and association with HLA. (1981) (21)
Rheumatoid vasculitis (1979) (21)
Nonlinkage of the T cell receptor α, β, and γ genes to systemic lupus erythematosus in multiplex families (1988) (21)
Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus. (1979) (20)
Neuropsychiatric syndromes in systemic lupus erythematosus: a new look. (1999) (20)
Antibody to serum amyloid A. (2004) (19)
Monocyte receptor function in patients with rheumatoid arthritis. (1981) (18)
Effects of intra-articular corticosteroids in vivo on synovial fluid variables in rheumatoid synovitis. (1974) (18)
Monoclonal gammopathy of undetermined significance and exposure to breast implants. (2001) (18)
The frequency of complement receptor type 1 (CR1) gene polymorphisms in nine families with multiple cases of systemic lupus erythematosus. (1989) (18)
Lateralized EEG Findings in Patients with Neuropsychiatric Manifestations of Systemic Lupus Erythematosus (2001) (18)
Rheumatoid synovitis: complement and immune complexes. (1961) (17)
Systemic lupus erythematosus is not genetically linked to the beta chain of the T cell receptor. (1986) (17)
Myeloperoxidase-antineutrophil Cytoplasmic Antibodies (MPO-ANCA) and Proteinase 3-ANCA without Immunofluorescent ANCA Found by Routine Clinical Testing (2015) (17)
Prevalence of allergen-specific IgE among patients with chronic fatigue syndrome. (2002) (16)
Monocyte function in systemic lupus erythematosus. (1989) (16)
IMMUNOLOGICAL IDENTIFICATION OF SUBPOPULATIONS OF MONONUCLEAR CELLS IN SARCOID GRANULOMAS * (1976) (15)
Vibrio fetus endocarditis in a patient with systemic lupus erythematosus. (1976) (15)
Laboratory Tests in Rheumatic Disorders (2012) (15)
Investigation of antibodies to extractable nuclear antigens in dogs. (1992) (15)
Radiologic findings in late-onset systemic lupus erythematosus. (1983) (15)
Immune function in sarcoidosis. Studies on delayed hypersensitivity, B and T lymphocytes, serum immunoglobulins and serum complement components. (1976) (14)
GLOMERULAR SCLEROSIS IN A RENAL ISOGRAFT AND IDENTICAL TWIN DONOR: A FAMILY STUDY (1984) (14)
Absence of Australia antigen and antibody in patients with rheumatic diseases. (1971) (14)
Autoantibodies to c-myc protein: elevated levels in patients with African Burkitt's lymphoma and normal Ghanians. (1992) (14)
Anticentromere antibodies--clinical correlates. (1988) (14)
Methylprednisolone pulse therapy for lupus nephritis: a followup study. (1984) (14)
Platelet-activating activity in synovial fluids of patients with rheumatoid arthritis, juvenile rheumatoid arthritis, gout, and noninflammatory arthropathies. (1980) (13)
Complement activation by antibodies to DNA in systemic lupus erythematosus measured by enzyme immunoassay. (1985) (13)
Elevated Anti–Citrullinated Protein Antibodies Prior to Rheumatoid Arthritis Diagnosis and Risks for Chronic Obstructive Pulmonary Disease or Asthma (2020) (13)
Interleukin-1 stimulation of human B-lymphoblast differentiation. (1988) (13)
Halothane and the liver: a review of the epidemiologic, immunologic and metabolic aspects of the relationship. (1972) (13)
Laboratory Evaluation of Patients with Systemic Lupus Erythematosus (2011) (13)
Isolation of Monoclonal Antibodies with Predetermined Conformational Epitope Specificity (2012) (13)
Systemic Lupus Erythematosus (2015) (13)
It is lupus? (1997) (13)
The effect of adherent cell-derived factors on immunoglobulin and anti-DNA synthesis in systemic lupus erythematosus. (1987) (12)
Lymphocytotoxic antibodies. HLA antigen associations, disease associations, and family studies. (1977) (12)
Immunoglobulin heavy chain constant-region gene polymorphism in systemic lupus erythematosus. (2010) (12)
Lectin-dependent neutrophil-mediated cytotoxicity. II. Possible mechanisms. (1976) (12)
Phylogeny of complement components in non-human primates. (1975) (12)
Serial serum free light chain measurements do not detect changes in disease status earlier than electrophoretic M-spike measurements in patients with intact immunoglobulin myeloma. (2011) (11)
Complement-Fixing Properties of Pepsin-Treated Rabbit and Sheep Antibodies (1963) (11)
Immunological characterization of subpopulations of mononuclear cells in tissue and peripheral blood from patients with sarcoidosis. (1976) (11)
Congenital deficiency of C2 and factor B. (1978) (11)
Anti-cyclic citrullinated peptide antibodies are strongly associated with risk of rheumatoid arthritis after adjusting for hormonal and behavioral factors (2005) (10)
A comparative study on clinical and serological characteristics between patients with rhupus and those with systemic lupus erythematosus and rheumatoid arthritis (2020) (10)
The gammaG subclass of antinuclear and antinucleic acid antibodies. (1972) (10)
Autoantibodies to Tumor Necrosis Factor in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus (2009) (10)
Association of Measles Virus with Rheumatoid Arthritis (2009) (10)
Autoantibodies, autoimmune risk alleles and clinical associations in rheumatoid arthritis cases and non-RA controls in the electronic medical records (2013) (10)
Laboratory Abnormalities in Patients with Chronic Fatigue Syndrome (1994) (9)
CD4 TCRBV CDR3 Analysis in prevalent SLE Cases from two ethnic Groups (1999) (9)
The development of an ELISA method for the detection of "antibodies" to silicone. (1996) (9)
The relationship between Sm and RNP antigens. (1986) (8)
Immunologic abnormalities in patients with malignant lymphoproliferative diseases. (1977) (8)
Proceedings: Distribution of HL-A antigens in patients with juvenile rheumatoid arthritis (JRA). (1975) (8)
Low sensitivity of plasma DNA in screening for pulmonary embolism. (1982) (8)
Therapeutic studies in NZB/W mice. IV. Effect of combination drug therapy on immune complex deposition. (1976) (8)
Lupus anticoagulant testing using two parallel methods detects additional cases and predicts persistent positivity (2018) (8)
Antibodies to T- and L-isoforms of the cytoskeletal protein, fimbrin, in patients with systemic lupus erythematosus. (1992) (8)
IgG subclass studies of C3 nephritic factor. (1978) (7)
Sharing of HLA haplotype by parents of patients with systemic lupus erythematosus. (1983) (7)
Fingerprint analysis of patients with systemic lupus erythematosus and their relatives. (1990) (6)
Complement Components in Rheumatic Diseases (1985) (6)
Systemic lupus erythematosus and complement. (1988) (6)
International collaborative study of four candidate reference preparations for the antigenic and hemolytic measurement of human serum complement components. (1981) (6)
Improved method for cloning human B-cell lines. (1982) (6)
Nonlinkage of the T cell receptor alpha, beta, and gamma genes to systemic lupus erythematosus in multiplex families. (1988) (6)
PEPSIN DIGESTION OF RABBIT AND SHEEP ANTIBODIES (1963) (5)
Allergic interstitial nephritis: report of a case with activation of complement by the alternate pathway. (1975) (5)
The Complement System in Rheumatoid Synovitis: The Relationship of Synovial Fluid Complement Levels to the Clinical, Radiological, and Pathological Changes in Rheumatoid Arthritis (1972) (5)
Glomerular localization of DNA and antibodies to nuclear constituents. (1967) (5)
Immunoglobulin subclass levels in chronic fatigue syndrome (1996) (5)
Stimulation of B cell differentiation by adherent mononuclear cells in systemic lupus erythematosus. (1987) (4)
Circulating immune complex levels in patients with gestational trophoblastic neoplasia. (1982) (4)
Hereditary C2 Deficiency: HLA Gene Complex Associations with Recombinant Events (1976) (4)
Use of nuclear antigen-coated red cells in hemolytic plaque assays. (1983) (4)
C-reactive protein, anti-C-reactive protein antibodies and clinical atherosclerosis (2008) (4)
Controlled study of azathioprine in lupus. (1968) (4)
Ordering of genes for HLA antigens and complement components on the human 6th chromosome. (1977) (4)
The amperometric titration of total and inter-chain disulfide bonds in γ-globulin (1965) (4)
Hemolytic assay of the ninth complement complement component: elevation and depletion in rheumatic diseases. (1971) (3)
Pathophysiology of rheumatic diseases. (1977) (3)
Case 5-2003: a 16-year-old girl with a rash and chest pain. (2003) (3)
To What Extent Can Preventive Treatments Prevent Damage From Systemic Lupus Erythematosus? (2011) (3)
Infected acute myocardial infarct with rupture in systemic lupus erythematosus. (1987) (3)
Are There Patients with Inflammatory Disease Who Do Not Respond to Prednisone? (2010) (2)
Third International Conference on Systemic Lupus Erythematosus. (1992) (2)
CHARACTERIZATION OF NATIVE AND RECOMBINANT INTERLEUKIN-1 INHIBITOR ON T CELL, MONOCYTE, AND B CELL RESPONSE TO INTERLEUKIN-1 (1992) (2)
Arthritis And Autoimmunity (1994) (2)
THE AMPEROMETRIC TITRATION OF TOTAL AND INTER-CHAIN DISULFIDE BONDS IN GAMMA-GLOBULIN. (1965) (1)
Proceedings: Antibodies to DSDNA in patients with rheumatic disease other than systemic lupus (SLE). (1975) (1)
Subclass Immunoglobulins and Circulating Immune Complexes IgG Subclasses in Human Periodontal Disease: III. Serum Concentrations of IgG (2011) (1)
Different indirect immunofluorescence ANA substrate performance in a diagnostic setting of patients with SLE and related disorders: retrospective review and analysis (2020) (1)
Abundance of DR2/DR3 and DR2/DR7 heterozygotes in Caucasian patients with systemic lupus erythematosus from USA. (1991) (1)
A Solid Phase Radio-Immuno Assay for Platelet-Bound IgG Employing 125-I protein Extraction of 7S IgG and Identification of Its Subclasses (1979) (1)
Antigammaglobulins in normal individuals and in patients with adult and juvenile rheumatoid arthritis and osteoarthritis. (1975) (1)
HTLV-III antibody testing in sperm donors. (1985) (1)
IgG subclasses in asthmatic patients. (1983) (1)
IgG Subclass Studies of C3 Nephritic Factor (C3NeF) (1978) (1)
The human IgG subclasses: Molecular analysis of structure, function, and regulation: Edited by Farouk Shakib. Oxford, Pergarnon Press, 1990, 316 pp (1992) (1)
THU0689 ASTHMA AND ELEVATION OF ANTI-CITRULLINATED PROTEIN ANTIBODIES PRIOR TO THE ONSET OF RHEUMATOID ARTHRITIS (2019) (1)
A New Genetic Determinant of γG3 1 (1976) (1)
Serologic Evaluation in the Rheumatology-Dermatology Overlap Patient (2022) (0)
Detection of SARS-CoV-2 Antibodies in Diagnosis and Treatment of COVID-19 (2022) (0)
James Sydney Stillman, MD, 1908--1998. (1999) (0)
Chronic Fatigue Syndrome (and Chronic Fatigue) (2019) (0)
Complement genetics. (1989) (0)
What is an "important" article? Reflections of an Arthritis & Rheumatism editor, 1990-1995. (2008) (0)
EULAR Task Force on Systemic Lupus Erythematosus: a critical appraisal (2008) (0)
FOR ENRICHING AIR WITH AN AIR TREATMENTAGENT , ESPECIALLY FOR THE DISINFECTION OF AIR , AND / OR PERFUMING OF AIR AND / OR FOR ODOR MASKING ( 76 ) Inventor : Jorg (2017) (0)
Laboratory testing for the diagnosis, evaluation, and management of systemic lupus erythematosus: Still more questions for the next generations: A Tribute and Thanks and in Memory of my mentor: Henry G. Kunkel. (2016) (0)
Isolation of neutralizing monoclonal antibodies against HIV-1 with predetermined conformational epitope specificity (76.4) (2012) (0)
Treatment of Systemic Lupus Erythematosus (2002) (0)
Influence of ballet season on radiology reports (1996) (0)
The gamma heavy-chain subclass of bound antiplatelet antibody was examined in six patients with autoimmune thrombocytopenic purpura (ATP) by a solid-phase radioimmunoassay. Monospecific antisera for 'yGl (2011) (0)
Arthritis and autoimmunity. The Fifteenth Sigrid Juselius International Symposium. (1994) (0)
[ HLA-B 8 , SC 01 , DR 3 ] conserved extended (2009) (0)
Perspectives on Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 and Its Implications for Diagnostics, Biology, and Clinical Management (2021) (0)
Genetic Defects of the Complement Pathways: Relationship to HLA and Disease (1983) (0)
Immunologic Studies of Juvenil e Rheumatoid Arthritis (1971) (0)
Correction: IgE, Not IgG (1971) (0)
From Paris to Vienna-The Varied Names and Descriptions of Cutaneous Lupus Erythematosus in the 19th Century. (2017) (0)
Autoantibody to the C 3 b / C 4 b Receptor and Absence of this Receptor from Erythrocytes of a Patient with Systemic Lupus Erythematosus (2013) (0)
Diagnosing and Monitoring Lupus (2012) (0)
nomenclature of a and r 1983 (2015) (0)
Cellular control of antinuclear antibody production. Anti-dsDNA and anti-Sm plaque forming cells in SLE patients and normal individuals. (1985) (0)
Excerpts from classics in allergy. second edition. Second edition. Edited by Sheldon G. Cohen and Max Samter. Carlsbad, CA, Symposia Foundation, 1992. 211 pp. Illustrated. Indexed. (1993) (0)
JUVENILE RHEUMATOID ARTHRITIS CELLULAR HYPERSENSITIVITY AND SELECTIVEIgADEFICIENCY (1972) (0)
Guest Editors' Foreword (1999) (0)
Surveying our readers and authors (1995) (0)
The Treatment of Lupus: General Principles (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Peter H. Schur?

Peter H. Schur is affiliated with the following schools: